Cardioverter Defibrillator Devices Market – Global Opportunity Analysis And Industry Forecast (2017-2022)
Cardioverter Defibrillator Devices Market Size by Product [Implantable Cardioverter Defibrillator (Transvenous Cardioverter Defibrillator, Subcutaneous Cardioverter Defibrillator), External Cardioverter Defibrillator (Manual External Defibrillator, Automated External Defibrillator, and Wearable External Defibrillator)], and End-User (Hospitals, Ambulatory Surgical Centers, and Others) - Global Opportunity Analysis and Industry Forecast To 2022.
Increasing prevalence of cardiovascular disease, sudden cardiac arrest (SCA), and related death remains a significant public health issue across the globe. Variety of non-pharmacologic therapies for primary and secondary prevention of SCA and their management including implantable and wearable defibrillators are available in the market. Cardioverter defibrillators have become a significant therapeutic modality among all for patients who have had a cardiac arrest or are at risk for life-threatening ventricular arrhythmias.
Numerous technological advances in implantable cardioverter defibrillators have resulted in decreased size, greater ease of placement, increased functionality, and improved efficiency to better manage the critical cardiac conditions, thereby driving its adoption across the globe.
The global cardioverter defibrillator devices market is expected to reach USD 12,520.0 million by 2022, at a CAGR of 4.6% during the forecast period of 2017-2022. Increasing burden of cardiovascular diseases, rising aging population, various technological advancements, and increasing sedentary lifestyle and obesity along with excessive consumption of alcohol & caffeinated products are the key factors driving the growth of this market. In addition to the key drivers, the report further gives an extensive outlook on key industry restraints, and opportunities, listed in the market insights segment.
This comprehensive study on the basis of product types and end users gives an extensive outlook on the key dynamics, trends, advantages, key players, related statistics, and detailed market size & forecasts for each segment and sub-segment covered in the cardioverter defibrillator devices market.
The regional focus of the study has covered five major geographies: North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. These regions are further analysed at a country level with the detailed qualitative and quantitative analysis. The geographic analysis provides detailed insights on the key trends of the industry in the listed regions & countries, identifying the demographic & economic impact, government & private investments, and regulatory scenario. The report identifies North America to be the largest market, followed by Europe, Asia-Pacific, Latin America, and Middle East & Africa. The geographic analysis section also comments on the key market players shaping the growth of the industry in the respective countries.
The report also includes the competitive landscape based on extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past 4 years (2014-2017). The study has also incorporated the market share analysis of leading players and detailed profiles of top 13 market players across the value chain of the industry, including detailed financial performance, product offerings, and strategic growth initiatives of each player.
The key players operating in the global cardioverter defibrillator devices market are Medtronic PLC (Ireland), Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK SE & Co. KG (Germany), LivaNova PLC (U.K.), Stryker Corporation (U.S.), Koninklijke Philips N.V. (The Netherlands), Cardiac Science corporation (U.S.), Zoll medical corporation (U.S.), Nihon Kohden Corporation (Japan), Progetti Srl (Italy), Fukuda Denshi Co. (Japan), and Schiller AG (Switzerland).
Key questions answered in the report: